Best Biotech Stocks

QQQ ETF Update, 5/16/2024

How is QQQ stock faring? The Invesco QQQ ETF is up 2.15% in the past 5 days and has risen...

21h ago

AEP

Eisai/Biogen initiate FDA BLA for LEQEMBI

Eisai Co., (ESALY) and Biogen Inc. (BIIB) “announced that Eisai has initiated the rolling submission of a Biologics...

2d ago

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO:...

2d ago

Gilead’s Kite data at EHA 2024 demonstrate ‘positive’ patient outcomes

Kite, a Gilead Company, announced 12 abstracts from its Chimeric Antigen Receptor T-cell therapy portfolio at the upcoming...

3d ago

Early notable gainers among liquid option names on May 14th

Notable gainers among liquid option names this morning include Insulet (PODD) $171.70 +10.68, Illumina (ILMN) $119.53 +6.76, Enphase...

3d ago

COO

ENPH

Roblox downgraded, Western Digital initiated: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

3d ago

GXO

Xilio Therapeutics expects cash to fund operations into Q2 of 2025

Based on its current operating plans, Xilio (XLO) anticipates that its existing cash and cash equivalents as of...

3d ago

XLO

QQQ ETF Update, 5/14/2024

How is QQQ stock faring? The Invesco QQQ ETF is up 0.67% in the past 5 days and has risen...

3d ago

AEP

Moderna initiated with an In Line at Evercore ISI

Evercore ISI initiated coverage of Moderna with an In Line rating and $120 price target. While “intrigued” by...

4d ago

MRNA

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

Biogen

Buy

Reiterated

2024-05-16

AMGN

Amgen

Hold

Upgraded

2024-05-16

REGN

Regeneron

Buy

Assigned

2024-05-15

MRNA

Moderna

Buy

Assigned

2024-05-15

ILMN

Illumina

Hold

Reiterated

2024-05-14

VRTX

Vertex Pharmaceuticals

Buy

Assigned

2024-05-10

BNTX

BioNTech SE

Hold

Reiterated

2024-05-10

IQV

IQVIA Holdings

Buy

Reiterated

2024-05-08

Gilead Sciences

Buy

Reiterated

2024-05-01

Biogen

Hold

Reiterated

2024-05-16

All Ratings >

Most Recent Earnings of Biotech Stocks

Gilead Sciences

Apr 25, 2024

Mar 01, 2024

-1.49 / -1.32

1.34

AMGN

Amgen

May 02, 2024

Mar 01, 2024

3.88 / 3.96

VRTX

Vertex Pharmaceuticals

May 06, 2024

Mar 01, 2024

4.07 / 4.76

3.89

Biogen

Apr 24, 2024

Mar 01, 2024

3.47 / 3.67

4.02

ILMN

Illumina

May 02, 2024

Mar 01, 2024

0.04 / 0.09

0.32

REGN

Regeneron

May 02, 2024

Mar 01, 2024

10.17 / 9.55

10.24

MRNA

Moderna

May 02, 2024

Mar 01, 2024

-3.56 / -3.07

-3.62

IQV

IQVIA Holdings

May 02, 2024

Mar 01, 2024

2.49 / 2.54

2.43

BNTX

BioNTech SE

May 06, 2024

Mar 01, 2024

-1.35 / -1.43

-0.79

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

Biogen - Strong Buy, based on 24 analyst ratings, 18 Buy, 6 Hold, and 0 Sell.

Regeneron - Strong Buy, based on 20 analyst ratings, 16 Buy, 3 Hold, and 1 Sell.

IQVIA Holdings - Strong Buy, based on 13 analyst ratings, 12 Buy, 1 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $67.86, and its average 12-month price target is $81.30.

Amgen's stock price is currently $314.72, and its average 12-month price target is $322.75.

Vertex Pharmaceuticals's stock price is currently $440.64, and its average 12-month price target is $457.73.

Biogen's stock price is currently $230.04, and its average 12-month price target is $287.27.

Illumina's stock price is currently $114.46, and its average 12-month price target is $157.25.

Regeneron's stock price is currently $967.98, and its average 12-month price target is $1,058.17.

Moderna's stock price is currently $132.68, and its average 12-month price target is $130.29.

IQVIA Holdings's stock price is currently $235.00, and its average 12-month price target is $276.75.

BioNTech SE's stock price is currently $92.98, and its average 12-month price target is $110.58.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.77 which represents an annual dividend yield of 4.46%. Gilead Sciences's next Ex-dividend date is June 14, 2024 and its next payout date is June 27, 2024.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.

Latest News

DOCS Earnings: Doximity Stock Gains on Impressive Q4 Report

DOCS

Who Owns Lightspeed Stock?

LSPD

Boeing’s Supplier SPR Cuts Jobs Amid Production Slump

ALK

Stock Market News Today, 5/17/24 – Futures Flat After a Strong Session

NDX

SPX

Class Action Lawsuit against HireRight Holdings Corp. (NYSE:HRT)

HRT

M&A News: Snowflake to Acquire Reka AI

SNOW

JPMorgan Stock (NYSE:JPM): Worth the Money? Or Should You Look Overseas?

JPM

Billionaire Ray Dalio’s Stark Warning for American Investors

Has Super Micro Computer Stock (NASDAQ:SMCI) Really Peaked?

AMZN

GOOG

Microsoft Stock: ‘Don’t Overlook This Tailwind,’ Says Piper Sandler

MSFT

‘Wait for Better Visibility,’ Says RBC About Rivian Stock

RIVN

‘Don’t Expect Another Rally on May 22,’ Says Piper Sandler About Nvidia Stock

NVDA

Chubb (NYSE:CB): Value Stock Alert — Buffett’s Secret $6.7B Investment Revealed

Wayfair (NYSE:W) Plans to Open First Physical Location